Overall, a growing body of evidence indicates that SMYD3 is an essential epigenetic regulator that methylates histone and non-histone substrates, orchestrating protein-protein and protein-DNA interactions; however, its epigenetic role in cancer is not fully understood yet. This evidence concerns the gene SMYD3 and cancer.